---
input_text: Electroacupuncture Improves Motor Symptoms of Parkinson's Disease and
  Promotes Neuronal Autophagy Activity in Mouse Brain.Autophagic defects are a hallmark
  of neurodegenerative disorders, such as Parkinson's disorder (PD). Enhancing autophagy
  to remove impaired mitochondria and toxic protein aggregation is an essential component
  of PD treatment. In particular, activation of autophagy confers neuroprotection
  in cellular and preclinical models of neurodegenerative diseases. In this study,
  we investigated the therapeutic mechanisms of electroacupuncture (EA) treatment
  in mice with established PD and evaluated the relationship between EA, autophagy,
  and different neurons in the mouse brain. We report that EA improves PD motor symptoms
  in mice and enhances (1) autophagy initiation (increased Beclin 1), (2) autophagosome
  biogenesis (increased Atg5, Atg7, Atg9A, Atg12, Atg16L, Atg3, and LC3-II), (3) autophagy
  flux/substrate degradation (decreased p62), and (4) mitophagy (increased PINK1 and
  DJ-1) in neurons of the substantia nigra, striatum, hippocampus, and cortex (affected
  brain areas of PD, Huntington disease, and Alzheimer's disease). EA enhances autophagy
  initiation, autophagosome biogenesis, mitophagy, and autophagy flux/substrate degradation
  in certain brain areas. Our findings are the first to show that EA regulates neuronal
  autophagy and suggest that this convenient, inexpensive treatment has exciting therapeutic
  potential in neurodegenerative disorders.
raw_completion_output: |-
  primary_disease: Parkinson's Disease

  medical_actions: Electroacupuncture treatment;Enhancing autophagy

  symptoms: Motor symptoms

  chemicals: Beclin 1;Atg5;Atg7;Atg9A;Atg12;Atg16L;Atg3;LC3-II;p62;PINK1;DJ-1

  action_annotation_relationships: Electroacupuncture treatment TREATS Motor symptoms IN Parkinson's Disease;Enhancing autophagy (with Beclin 1) TREATS Autophagic defects IN Parkinson's Disease;Enhancing autophagy (with Atg5; Atg7; Atg9A; Atg12; Atg16L; Atg3; LC3-II) TREATS Autophagic defects IN Parkinson's Disease;Enhancing autophagy (with p62) TREATS Autophagic defects IN Parkinson's Disease;Enhancing autophagy (with PINK1; DJ-1) TREATS Autophagic defects IN Parkinson's Disease
prompt: |+
  Split the following piece of text into fields in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  DJ-1) TREATS Autophagic defects IN Parkinson's Disease

  ===

extracted_object:
  primary_disease: MONDO:0005180
  medical_actions:
    - Electroacupuncture treatment
    - Enhancing autophagy
  symptoms:
    - Motor symptoms
  chemicals:
    - Beclin 1
    - Atg5
    - Atg7
    - Atg9A
    - Atg12
    - Atg16L
    - Atg3
    - LC3-II
    - p62
    - PINK1
    - DJ-1
  action_annotation_relationships:
    - subject: <Electroacupuncture treatment>
      predicate: <TREATS>
      object: <Motor symptoms>
      qualifier: <Parkinson's Disease>
      subject_extension: <Electroacupuncture>
    - subject: Enhancing autophagy
      predicate: TREATS
      object: Autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with Beclin 1
      subject_extension: Beclin 1
    - subject: LC3-II
      predicate: TREATS
      object: Autophagic defects
      qualifier: MONDO:0005180
    - subject: Enhancing autophagy
      predicate: TREATS
      object: Autophagic defects
      qualifier: MONDO:0005180
      subject_qualifier: with p62
      subject_extension: p62
    - predicate: TREATS
      object: Autophagic defects
      qualifier: MONDO:0005180
      subject_extension: DJ-1
named_entities:
  - id: MONDO:0007739
    label: Huntington Disease (HD)
  - id: CHEBI:16908
    label: NADH
  - id: MAXO:0000065
    label: aerobic exercises
  - id: CHEBI:53444
    label: Potassium dichromate
  - id: MAXO:0000079
    label: genetic counseling
  - id: HP:0002072
    label: Chorea
  - id: HP:0000708
    label: behavioral problems
  - id: MAXO:0000127
    label: genetic testing
  - id: HP:0004421
    label: elevated systolic blood pressure
  - id: HP:0001288
    label: Gait disturbance
  - id: HP:0000716
    label: depression
  - id: HP:0000739
    label: anxiety
  - id: CHEBI:7872
    label: oxytocin
  - id: CHEBI:9937
    label: vasopressin
  - id: MONDO:0005071
    label: Neurological disorders
  - id: MAXO:0001001
    label: Gene therapy
  - id: HP:0033429
    label: Neuroinflammation
  - id: HP:0002180
    label: Neurodegeneration
  - id: HP:0100543
    label: Cognitive dysfunction
  - id: MAXO:0000016
    label: Cell Therapy
  - id: MAXO:0000068
    label: transplantation
  - id: HP:0001250
    label: Seizures
  - id: HP:0000750
    label: Language delay
  - id: HP:0033044
    label: Motor regression
  - id: HP:0001337
    label: Tremor
  - id: HP:0040141
    label: Tardive dyskinesia
  - id: MONDO:0010096
    label: tardive dyskinesia
  - id: HP:0010619
    label: Decrease in fractional anisotropy (FA)
  - id: CHEBI:16675
    label: Quinolinic acid
  - id: MONDO:0001627
    label: Dementias
  - id: MAXO:0000022
    label: Hospice care
  - id: CHEBI:192545
    label: LY379268
  - id: MONDO:0005559
    label: Neurodegenerative diseases
  - id: MAXO:0009004
    label: WES (Whole Exome Sequencing)
  - id: HP:0001251
    label: cerebellar ataxia
  - id: CHEBI:74869
    label: WES
  - id: HP:0005305
    label: cerebral venous thrombosis
  - id: HP:0001891
    label: iron-deficiency anemia
  - id: HP:0001875
    label: neutropenia
  - id: HP:0000657
    label: Ocular Motor Apraxia
  - id: HP:0025464
    label: Oxidative stress
  - id: HP:0003287
    label: Mitochondrial dysfunction
  - id: HP:0002511
    label: Alzheimer's disease
  - id: HP:0001297
    label: Stroke
  - id: HP:0012207
    label: Reduced sperm motility
  - id: MAXO:0000137
    label: PET scan
  - id: MONDO:0004975
    label: Alzheimer's disease
  - id: MAXO:0001000
    label: functional MRI
  - id: MAXO:0000969
    label: Optical coherence tomography (OCT)
  - id: CHEBI:50826
    label: Silver nanoparticles (Ag-NPs)
  - id: CHEBI:145810
    label: Insulin
  - id: CHEBI:36751
    label: principal component analysis (PCA)
  - id: CHEBI:76931
    label: N-acetylaspartylglutamate
  - id: MAXO:0000943
    label: Deep brain stimulation (DBS)
  - id: HP:0001332
    label: Dystonia
  - id: CHEBI:16348
    label: 3-nitropropionic acid
  - id: CHEBI:15765
    label: L-DOPA
  - id: MONDO:0024331
    label: Colorectal cancer (CRC)
  - id: MONDO:0005575
    label: Colorectal cancer
  - id: HP:0000238
    label: hydrocephalus
  - id: CHEBI:76720
    label: antisense oligonucleotides
  - id: MONDO:0005180
    label: Parkinson's Disease
